Synopsis:As the second generation NS5A inhibitor, vaepatavir has good antiviral activity against all HCV genotypes, common NS5A mutations and drug-resistant mutations in vitro.
Structural formula:
Properties
Summary
As the second generation NS5A inhibitor, vaepatavir has good antiviral activity against all HCV genotypes, common NS5A mutations and drug-resistant mutations in vitro.